MercedesPorosnicuMD

PubMed

• 17 citations
  Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma.
  Kimberly M. Burcher, Jeffrey Lantz, Elena Gavrila, Arianne Abreu, Jack T. Burcher
  Cancers. 2021-11-16
• 31 citations
  Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages
  Meng Yang, Umit Topaloglu, W. Jeffrey Petty, Matthew Pagni, Kristie L. Foley
  Journal of Hematology & Oncology. 2017-05-04
• 6 citations
  Human papillomavirus-related small cell carcinoma of the oropharynx: a case report and literature review
  Marcelo Bonomi, Tamjeed Ahmed, David S. Warner, Joshua D. Waltonen, Christopher A. Sullivan
  Cancers of the Head & Neck. 2017-02-06

Journal Articles

• Cotreatment with STI-571 enhances tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL or apo-2L)-induced apoptosis of Bcr-Abl-positive human acute leu...  
  Nimmanapalli R, Porosnicu M, Nguyen D, Worthington E, O'Bryan E, Perkins C, Bhalla K, Clin Cancer Res, 1/1/2001

Abstracts/Posters

• Retrospective Analysis of Cisplatin Nephrotoxicity in Head and Neck Cancer Patients Treated as Outpatient with Concurrent High-Dose Cisplatin and Radiotherapy
  M. Haughton, MD, J. Faig, M, R. B. D'Agostino, PhD, M. J. Whelan, MPH, M. Murea, MD, M. Porosnicu, MD, Multidisciplinary Head and Neck Symposium, 1/1/2014
• Phase I Clinical Trial of Re-irradiation with Pemetrexed and Erlotinib followed by Maintenance Erlotinib for Recurrent and Second Primary Squamous Cell Carcinoma of th...
  M. Porosnicu, MD, K. Greven, MD, N. Hayes, MD, B. Chera, MD, C. Sullivan, MD, J. D. Waltonen, MD, J. D. Browne, MD, Multidisciplinary Head and Neck Symposium, 1/1/2014
• Retrospective Analysis of the Impact of HPV Status and Smoking on Mucositis in Patients with Oropharyngeal Squamous Cell Carcinoma Treated with Concurrent Chemotherapy...
  M. Porosnicu, MD, M. Vatca, MD; J.T. Lucas, Jr., MS, MD, J. Laudadio, MD; R.B. D’Agostino, Jr., PhD; J.D. Waltonen, MD; C.A. Sullivan, MD; R. Rouchard-Plasser, PA-C; M..., Multidisciplinary Head and Neck Symposium, 1/1/2014
• Pilot study to evaluate the effect of erlotinib (E) administered before surgery in operable patients with squamous cell carcinoma of the head and neck (SCCHN).
  M. Porosnicu, J. D. Waltonen, C. Sullivan, L. McWilliams, G. L. Kucera, A. Thomas, A. Mintz, R. Plasser, J. D. Browne, Multidisciplinary Head and Neck Cancer Symposium, AZ, 1/1/2012
• Phase I/II Clinical Trial Of Re-irradiation With Pemetrexed And Erlotinib Followed By Maintenance Erlotinib For Recurrent And Second Primary Squamous Cell Carcinoma Of...
  M. Porosnicu, K. Greven, S. G. Butler, C. Sullivan, J. D. Waltonen, R. Plasser, J. D. Browne, Multidisciplinary Head and Neck Cancer Symposium, AZ, 1/1/2012
• Cryoablation as Salvage Therapy of Locally Recurrent Squamous Cell Laryngeal Cancer
  J. G. Mammarappallil, C. Sullivan, J. J. Urbanic, M. Porosnicu, J. Meyers, H. Clark, WCIO; World Conference on Interventional Radiology, Chicago, IL, 1/1/2012
• Pilot study to evaluate the effect of erlotinib (E) administered before surgery in operable patients with squamous cell carcinoma of the head and neck (SCCHN)
  M. Porosnicu, M. Vatca, J. D. Waltonen, C. Sullivan, L. McWilliams, G. L. Kucera, A. Thomas, R. Plasser, J. D. Browne, J Clin Oncol, 1/1/2011
• Radiation-Induced ROS Regulates Signaling and Metabolism in Head and Neck Cancers
  Revati Wani, M. Porosnicu, Allen W. Tsang and Cristina M. Furdui, Gordon Research Conference on Thiol-Based Redox Regulation & Signaling, Italy, 1/1/2010
• Susceptibility of head and neck cancer to an attenuated model of the oncolytic vesicular stomatitis virus expressing suicide genes
  M. Porosnicu, J. Liu, D. Lyles, J Clin Oncol, 1/1/2009
• Head and neck squamous carcinoma cells are susceptible to the attenuated vesicular stomatitis virus expressing suicide genes
  M. Porosnicu, J. Liu, D. Lyles, AACR-EORTC-NCI Molecular Targets and Cancer Therapeutics, 1/1/2009
• Gefitinib (ZD-1839) with concurrent docetaxel and conformal three-dimensional thoracic radiation followed by consolidative docetaxel/gefitinib for patients with stage ...
  Blackstock AW, Jensen C, Petty W, Oaks T, M. Porosnicu, Clark H, Lovato J, Miller A, Int J Radiat Oncol Biol Phys, 1/1/2007
• Gefitinig (ZD-1839) with concurrent docetaxel and conformal three-dimensional thoracic radiation followed by consolidative docetaxel/gefitinib for patients with stage ...
  Blackstock A, Petty J, Oaks T, M. Porosnicu, Clark H, Lovato J, Miller A, J Clin Oncol, 1/1/2007
• Molecular Targeted Therapy in Oncology
  Onofrei Oana, Cepareanu Raluca, Ciosnar Anca, Mercedes Porosnicu, Asklepios; 10th Scientific Meeting of Medical Students and Residents, Sibiu, Romania, 1/1/2004
• Evaluation of the role of Flowcytometry in the diagnosis of Acute Leukemia in adults
  Liliana Nedelcu, Irina Haivas, Mihaela Zlei, Mercedes Porosnicu, Timisoara Medical Journal; International Scientific Meeting for Medical Students and Young Doctors, Timisoara, Romania, 1/1/2004
• A Dilema in Glivec Era- Resistance
  Raluca Cepareanu, Oana Onofrei, Anca Morosanu, Mercedes Porosnicu, Marisiensis; 5th National Medical Students Conference, Tg. Mures, Romania, 1/1/2004
• Significance of immunofenotipic identification of myeloid markers in ALL
  Morosanu Anca, Mihaela Zlei, Raluca Cepareanu, Ramona Grosu, Mercedes Porosnicu, Medical Congress ARMED, Sibiu, Romania, 1/1/2004
• Glivec Era-Molecular Targeted Therapy in CML
  Oana Onofrei, Raluca Cepareanu, Mercedes Porosnicu, Marisiensis; 5th National Medical Students Conference, Tg. Mures, Romania, 1/1/2004
• Vesicular Stomatitis Virus exhibits selective oncolytic activity and high efficiency as an expression vector.
  M. Porosnicu, S. Balachandran, M. Fernandez, D. Markovic, H.Ezelle, G. Barber, Proceedings, 6th Annual Joint Cancer Conference of the Florida Universities, 1/1/2002
• Natural history, survival and management of patients with diagnosis of esthesioneuroblastoma
  Calfa C., Raez l., Porosnicu M., Weed D., Civantos F., Goodwin J., Sridhar K., Markoe A, Proceeding ASCO, 1/1/2002
• Expression of suicide genes increases the selective oncolytic effect of the Vesicular Stomatitis Virus
  Porosnicu M, Fernandez M, Balachandran S, Markovic D, Ezelle H, Barber GN, Proceeding ASCO; ASCO Annual Meeting, 1/1/2002
• Increased efficiency of the selectively oncolytic Vesicular Stomatitis Virus by genetic manipulation with expression of suicide genes.
  Porosnicu M, Fernandez M, Balachandran S, Markovic D, Ezelle H, Barber GN, Proceedings of AACR; AACR Annual Meeting, 1/1/2002
• Efficient and selective oncolytic activity of the wild-type and the recombinant Vesicular Stomatitis Virus
  Mercedes Porosnicu, S. Balachandran, M. Fernandez, H. Ezerelle, Glen Barber, Proceedings ASCO, 1/1/2001
• Vesicular Stomatitis Virus is an effective oncolytic agent against tumors exhibiting aberrant p53, Ras or Myc function and entails the induction of apoptosis.
  S. Balachandran, M. Fernandez, M. Porosnicu, H. Ezerelle, G. Barber, Proceedings AACR, 1/1/2001
• Genetically engineered vesicular stomatitis virus for use in gene therapy: Application for the treatment of malignant disease
  Fernandez M., Balachandran S., Porosnicu M., Markovic D., Barber G. N., Gene Therapy, 1/1/2001
• Co-treatment with STI-571 enhances TNFalpha related apoptosis inducing ligand (TRAIL or Apo-2L)- induced apoptosis of BCR-ABL positive human acute leukemia cells.
  Kapil N. Bhalla, N. Ramadevi, E. O’Brien, D. Nguyen, C. Perkins, M. Porosnicu, Blood; ASH, 1/1/2000
• Join now to see all

Lectures

• Chemotherapy for Head & Neck CA 
  WFBH - 1/1/2016
• Special Care Dentistry 
  Washington, DC - 1/1/2009
• Treatment of Squamous Cell Carcinoma of the Head and Neck 
  Watauga Medical Center in Boone - 1/1/2009
• Treatment of HNSCC 
  Rowen Regional Medical Center, Salisbury, NC - 1/1/2007
• Join now to see all